Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Population Assessment of Tobacco and Health (PATH) Study…

U.S. National Institutes of Health·United States of America

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

Closes 9/5/2026$100k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens and related research data on behaviors, attitudes, biomarkers, and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study. Key aspects of the job include: • Access to biospecimens (urine, plasma, serum, and genomic DNA) from the PATH Study • Related research data on behaviors, attitudes, biomarkers, and health outcomes associated with tobacco use • Opportunity for investigators to apply for access to the biospecimens • The PATH Study series page is available on the University of Michigan's National Addiction and HIV Data Archive Program (NAHDAP) website

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
8/24/2023
Closes
9/5/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-24-027

Budget estimate

$100,000 – $500,000

The budget for this grant is not explicitly stated, but based on the National Institutes of Health's typical grant funding, it could range from $100,000 to $500,000. The actual budget will depend on the scope of the project, the number of biospecimens requested, and the research plan proposed by the investigator. Factors that may influence the likely payment range include the complexity of the research, the number of personnel involved, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 81%

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

73% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

69% match

Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 3/1/2028Opened 5/14/2025

U.S. National Institutes of Health·United States of America

69% match

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Closes 10/8/2027Opened 11/21/2024

U.S. National Institutes of Health·United States of America

69% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

68% match

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Closes 5/7/2027Opened 8/16/2023

U.S. National Institutes of Health·United States of America

68% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

68% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

67% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

67% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

67% match

Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional)

Closes 11/9/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

67% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

U.S. National Institutes of Health·United States of America

67% match

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/8/2025

U.S. Food and Drug Administration·United States of America

67% match

REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

66% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

66% match

Discovery Gateway to Reproductive Health Innovation

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

66% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. Centers for Disease Control - NCEH·United States of America

66% match

State Biomonitoring Cooperative Agreement

Closes 5/18/2027Opened 9/22/2026

U.S. National Institutes of Health·United States of America

66% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. Food and Drug Administration·United States of America

66% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

66% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

66% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. Department Of Health And Human Services·United States of America

66% match

A--Risk Underlying Rural Areas Longitudinal (RURAL) H

Closes 11/5/2026Opened 9/14/2026

U.S. National Institutes of Health·United States of America

66% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026